Altria Group Inc. (NYSE:MO) shares moved down -0.24% in last trading session and ended the day at $61.86. MO Gross Margin is 43.70% and its has a return on assets of 19.10%. Altria Group Inc. (NYSE:MO) quarterly performance is 11.65%.
Altria Group, Inc. (NYSE:MO) announced that its Board of Directors declared a regular quarterly dividend of $0.565 per common share, payable on April 11, 2016, to shareholders of record as of March 15, 2016. The ex-dividend date is March 11, 2016.
Relypsa, Inc. (NASDAQ:RLYP) ended the last trading day at $12.94. Company weekly volatility is calculated as 8.51% and price to cash ratio as 2.33. Relypsa, Inc. (NASDAQ:RLYP) showed a weekly performance of -4.57%.
Relypsa, Inc. (NASDAQ: RLYP) discloses herein the new patient starts, outpatient prescriptions and units sold to hospitals/other institutions for the full month of February 2016 for Veltassa® (patiromer) for oral suspension.
On 15 March, Vince Holding Corp (NYSE:VNCE) shares moved down -6.62% and was closed at $7.33. Vince Holding Corp (NYSE:VNCE) year to date (YTD) performance is 60.04%.
Vince Holding Corp. (NYSE: VNCE), a leading contemporary fashion brand, announced that it plans to report its fourth quarter and 2015 financial results after-market on Tuesday, March 29, 2016. The Company also plans to hold a conference call to discuss its financial results on the same day at 4:15 p.m. ET.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares moved down -10.34% in last trading session and ended the day at $15.35. ESPR has a return on assets of -16.00%. Esperion Therapeutics, Inc. (NASDAQ:ESPR) quarterly performance is -38.67%.
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until March 14, 2016 to file lead plaintiff applications in a securities class action lawsuit against Esperion Therapeutics, Inc. (NASDAQ:ESPR). Investor losses must relate to purchases of the Company’s securities between August 18, 2015 and September 28, 2015. This action is pending in the United States District Court for the Eastern District of Michigan.
Editas Medicine Inc. (NASDAQ:EDIT) caters to the Healthcare space. Its weekly performance is -22.98%. On the last day of trading company shares ended up at $32.34.
Editas Medicine, Inc. (NASDAQ:EDIT), announced that it presented a company overview at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8, 2016 at 8:40 a.m. ET.
Leave a Reply